2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Critiquing the CDC Opioid Guideline: Some Light From the Heat

      1
      Clinical Pharmacology & Therapeutics
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Released in 2016, the Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain has been met with both praise and criticism. In this issue of the Journal, two commentaries address the guideline's strengths and limitations. While the authors differ in their assessment of the guideline, they share a common objective: safer opioid prescribing. Followed carefully, the CDC guideline will facilitate this, but followed carelessly it has the potential to cause harm.

          Related collections

          Author and article information

          Journal
          Clinical Pharmacology & Therapeutics
          Clin. Pharmacol. Ther.
          Wiley
          00099236
          June 2018
          June 2018
          March 30 2018
          : 103
          : 6
          : 966-968
          Affiliations
          [1 ]Divisions of General Internal Medicine and of Clinical Pharmacology and Toxicology, Department of Medicine; University of Toronto; Toronto ON Canada
          Article
          10.1002/cpt.1061
          29603206
          1d6fa628-10dd-42d2-be85-8650344b3836
          © 2018

          http://doi.wiley.com/10.1002/tdm_license_1.1

          http://onlinelibrary.wiley.com/termsAndConditions#vor

          History

          Comments

          Comment on this article